We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$9.6B
AUM Growth
+$506M
Cap. Flow
-$208M
Cap. Flow %
-2.17%
Top 10 Hldgs %
16.85%
Holding
2,391
New
63
Increased
104
Reduced
1,016
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 18.02%
2 Financials 14.83%
3 Healthcare 13.13%
4 Industrials 10.01%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FN icon
1076
Fabrinet
FN
$20.5B
$1.05M 0.01%
16,270
MEDP icon
1077
Medpace
MEDP
$16.2B
$1.05M 0.01%
12,542
ARES icon
1078
Ares Management
ARES
$32.1B
$1.05M 0.01%
29,429
HI
1079
DELISTED
Hillenbrand
HI
$1.05M 0.01%
31,487
+4,930
+19% +$156K
IVR icon
1080
Invesco Mortgage Capital
IVR
$802M
$1.05M 0.01%
6,298
CMPR icon
1081
Cimpress
CMPR
$2.4B
$1.05M 0.01%
8,313
-807
-9% -$105K
RARE icon
1082
Ultragenyx Pharmaceutical
RARE
$2.65B
$1.04M 0.01%
24,462
TMHC
1083
DELISTED
Taylor Morrison
TMHC
$1.04M 0.01%
47,598
AIMC
1084
DELISTED
Altra Industrial Motion Corp
AIMC
$1.04M 0.01%
28,671
SANM icon
1085
Sanmina
SANM
$11.2B
$1.03M 0.01%
30,166
DIOD icon
1086
Diodes
DIOD
$4.93B
$1.03M 0.01%
18,315
ESGR
1087
DELISTED
Enstar Group
ESGR
$1.03M 0.01%
4,985
ENSG icon
1088
The Ensign Group
ENSG
$10.6B
$1.03M 0.01%
22,721
-1,568
-6% -$66.2K
XLRN
1089
DELISTED
Acceleron Pharma
XLRN
$1.03M 0.01%
19,395
WSBC icon
1090
WesBanco
WSBC
$4.07B
$1.03M 0.01%
27,151
+3,381
+14% +$126K
ARQL
1091
DELISTED
Arqule Inc
ARQL
$1.02M 0.01%
51,349
ARNA
1092
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.02M 0.01%
22,490
ELME
1093
Elme Communities
ELME
$144M
$1.02M 0.01%
34,947
ROG icon
1094
Rogers Corp
ROG
$2.48B
$1.02M 0.01%
8,166
CADE
1095
DELISTED
Cadence Bancorporation
CADE
$1.02M 0.01%
56,137
AIN icon
1096
Albany International
AIN
$1.81B
$1.01M 0.01%
13,340
ZGNX
1097
DELISTED
Zogenix, Inc.
ZGNX
$1.01M 0.01%
19,414
SAIA icon
1098
Saia
SAIA
$10.1B
$1.01M 0.01%
10,845
ESE icon
1099
ESCO Technologies
ESE
$7.78B
$1.01M 0.01%
10,899
LPSN icon
1100
LivePerson
LPSN
$34.1M
$1.01M 0.01%
1,812

Similar funds

MetLife Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, MetLife Investment Management held 2,391 positions worth $9.6B, up 5.6% from $9.09B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management's Q4 2019 filing shows 63 new, 104 increased, 1,016 reduced and 90 closed positions. Its largest new stake was ServiceNow: 250,510 shares worth $14.1M. The largest sale was Celgene Corp, an estimated $19.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2019 buy was ServiceNow: 250,510 shares worth $14.1M.
  • MetLife Investment Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $10.2M increase.
  • MetLife Investment Management's biggest Q4 2019 reduction was Apple, cutting an estimated $12M.
  • MetLife Investment Management fully exited Celgene Corp in Q4 2019, selling an estimated $19.2M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $9.6B portfolio in Q4 2019.
  • MetLife Investment Management opened 63 new positions and closed 90 in Q4 2019.
  • MetLife Investment Management's portfolio value rose 5.6% quarter-over-quarter to $9.6B.

Based on MetLife Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.